NCT02974725 2025-04-13A Phase Ib Study of LXH254-centric Combinations in NSCLC or MelanomaNovartisPhase 1 Terminated241 enrolled
NCT01777776 2016-09-13Safety and Efficacy of LEE011 and LGX818 in Patients With BRAF Mutant Melanoma.Array BioPharmaPhase 1/2 Terminated28 enrolled 14 charts